IDiyas

For the Inventor, By the Inventor

Velbert, Germany

Hartwig Muller

USPTO Granted Patents = 9

Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Wuppertal, DE (1996)
  • Velbert, DE (1987 - 1998)

Company Filing History:

goldMedal9 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1987-1998

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5821222 - Cyclic depsipeptides having 18 ring atoms for combating endoparasites (1998-10-13),
2. 5624897 - Cyclic depsipeptides having 18 ring atoms, and their use for combating (1997-04-29),
3. 5492896 - Pseudopeptides having an antiviral action (1996-02-20),
4. 5185326 - Efomycins A, E and G as antiinflammatory agents (1993-02-09),
5. 5089487 - Circulation-active dibenzo[1,5]dioxocin-5-ones (1992-02-18),
6. 5073369 - Efomycins as performance promoters in animals (1991-12-17),
7. 4927810 - Efomycin G and it's use as yield promoter in animals (1990-05-22),
8. 4770876 - Microbiological production of livestock growth-promoting agent (1988-09-13),
9. 4670260 - Antibiotic for animal feeds (1987-06-02),

Title: Hartwig Muller: Innovator in Cyclic Depsipeptides

Introduction

Hartwig Muller is a notable inventor based in Velbert, Germany. He has made significant contributions to the field of medicine and veterinary medicine through his innovative work on cyclic depsipeptides.

Latest Patents

Muller holds 9 patents, with his latest inventions focusing on cyclic depsipeptides having 18 ring atoms. These compounds are designed for combating endoparasites. His patents include the use of cyclic depsipeptides of the general formula (I), where R.sup.1 to R.sup.6 have specific meanings as described in his work. These inventions not only highlight the preparation of these cyclic depsipeptides but also their application in both human and veterinary medicine.

Career Highlights

Muller is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work has been instrumental in advancing the understanding and application of cyclic depsipeptides in combating parasitic infections.

Collaborations

Throughout his career, Muller has collaborated with esteemed colleagues such as Erwin Bischoff and Klaus Frobel. These partnerships have contributed to the successful development and implementation of his innovative ideas.

Conclusion

Hartwig Muller stands out as a significant figure in the field of cyclic depsipeptides, with a focus on combating endoparasites. His contributions continue to impact both medicine and veterinary practices, showcasing the importance of innovation in these fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…